Meet Julian Schneider from Synopsys QuantumWise at the International Conference Argent - Advanced Radiotherapy, Generated by Exploiting Nanoprocesses and Technologies.
The conference will take place at CNRS, Univ. Paris-Saclay, Gif-sur-Yvette (Paris region), France, 22-24 Jan, 2018.
Synopsys QuantumWise is part of the intersectorial and multidisciplinary ITN (Initial Training Network) Argent. The aim of Argent is "to create a new generation of researchers and experts able to develop and propose to the society new tools and concepts for the improvement of cancer therapy treatments’’.
About Argent Conference
Cancer remains a major European health concern. More than 50% of patients receive radiotherapy as part of their cancer treatment. The main limitations of this treatment are the lack of tumour selectivity, which causes severe side effects, and the radioresistance of tumours. Highly promising approaches to improve the performances of radiation-based therapies include advanced radiation protocols (such as fast ion beam radiation or ultra-high-dose rate radiation) and nanoparticles-enhanced therapies.
This international conference brings together World leading researchers of different disciplines: physicists and medical physicists, chemists, biologists, medical doctors and SMEs with the aim of presenting their results of exploiting and understanding the nanoscale processes, towards the development and optimization of new nanodrugs together with novel radiation protocols – a high-excellence effort that should lead to a new era for radiotherapy with subsequent economic and quality of life benefits for the population.
Biological effect of nanoparticles combined with photon or particle therapy
Elementary mechanisms and nanodosimetry
Nanomaterials for radiation-based cancer therapies
Simulations of radiation effects
Medical and industrial perspectives
CALL FOR ABSTRACTS
September 18th - November 20th, 2017